Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?

KalVista Pharmaceuticals, Inc. (KALV) closed the last trading session at $15.24, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $33.22 indicates an 118% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $5.52. While the lowest estimate of $22.00 indicates a 44.4% increase from the current price level, the most opti ...